📰 ET Markets 🔴 BEARISH 🕒 05 Nov 2026, 07:43 AM IST

Zydus Lifesciences Q2 net profit falls 26.6% to Rs 925.5 crore

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Zydus Lifesciences Q2 net profit falls 26.6% to Rs 925.5 crore

📊

Market & Financial Impact: Zydus Lifesciences reported a net profit of ₹925.5 crore for the September quarter, which declined by 26.6%. The company's revenue from operations increased by 29.2% to ₹7,909.6 crore during the same period. Total expenses rose significantly to ₹6,806.6 crore, impacting profitability. The pharmaceuticals business contributed 83% to overall sales, with revenue from India formulations at ₹1,884.4 crore. North America formulations reported revenue of ₹3,314.5 crore, highlighting strong global performance.

💡

Actionable Insight: 🔴 Bearish Risk: Regulatory scrutiny, profit decline, or sell-off risk may create near-term volatility.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Some elections matter more than you know: No crop changed in the fields, yet sugar, coffee and soya got cheaper in a day

You can buy a walkie-talkie online. But can you legally use it?

KYB and KYC: Quick commerce, the Damani premium and what DMart must deliver – 3rd and concluding part

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Zydus Lifesciences Q2 net profit falls 26.6% to Rs 925.5 crore

🔥 More Live Market Stories

Citi employee killed in shooting at Florida office, suspect dead

GIFT Nifty surges 370 pts, signals strong start for Sensex, Nifty as crude oil plunges after US Midterm results

Blue wave stock rotation sinks Asian chipmakers, boosts autos

Natera co-founder director Jonathan Sheena sells $44,796 in shares

Natera executive chairman Matthew Rabinowitz sells $299,214 in shares

Natera CEO Steven Chapman sells $1.56 million in Natera common stock